Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
590 Anti-CD33 actinium-225 targeted radioimmunotherapy enhances the biologic activity of anti-CD47 antibody immunotherapy in preclinical models of acute myeloid leukemia
Compose a Response to This Article
Other responses
No responses have been published for this article.